Cell Signaling & Trafficking Structures Recommendations
To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
Sign in | Subscribe | Recommend to Library
New to F1000? See this week’s top article below for a free preview of a Recommendation.
SECTION HEADS
-
Laboratory of Molecular Biology, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH), Bethesda, MD, USA
-
Department of Biochemistry, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA
Section Topics
- » Apoptotic pathways
- » Extracellular receptor ligand interactions
- » G-Protein coupled receptor signaling
- » Intracellular receptor domain interactions
- » Kinases & phosphatases
- » Nuclear import/export
- » Second messenger generation & responses
- » Signaling in the immune system
- » Small GTPases & their regulation
- » Vesicle targeting & fusion
LATEST RECOMMENDATION
Tatiana Kutateladze and Catherine Musselman, University of Colorado, Anschutz Medical Campus, USA. F1000 Structural Biology
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
9 Recommendations, most recent by
Youxing Jiang, University of Texas Southwestern Medical Center at Dallas, USA. F1000 Structural Biology
- New Finding
- Novel Drug Target
- Technical Advance
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
